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Abstract Injectable hyaluronic acid (HA) derivatives are the
most used resorbable dermal fillers used for soft tissue aug-
mentation. While their use is considered safe, there have been
reports of cutaneous granulomatous reactions.We describe the
clinical, radiological, and cytological findings in a patient who
presented a full year after cosmetic treatment with HA injec-
tions and discuss the various treatment options.
Level of Evidence: Level V, therapeutic study.
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Introduction
Cosmetic procedures are becoming ever more popular [1] but
standards among clinics and practitioners varies. Aggressive
marketing techniques are sometimes used, and patients are
often under the impression that the procedure is risk free and
may be undertaken lightly. Indeed, when asked if they have
ever had an operation, many patients fail to include cosmetic
procedures as they do not view them as “proper” operations.
Furthermore, regulation in many countries is lacking[2]. Pub-
lic hospitals are sometimes left with the impression that when
things go wrong, they are left to salvage the situation and deal
with the dissatisfied patient.
It is against this backdrop that we report a case of delayed
granulomatous reaction to a facial filler.
Case report
The 53-year-old female patient presented to the University
Hospital Zurich Eye clinic in January 2013. She had been seen
3 days previously in an external walk-in clinic with unspecific
complaints relating to her left cheek. Despite receiving no
diagnosis, she had been prescribed co-amoxiclav orally and
told to return if the symptoms did not improve. The patient,
unsatisfied with this course of action, self-referred to the Eye
clinic where, after a normal ophthalmological examination
was referred for an ear, nose and throat (ENT) consult.
A detailed history revealed the patient to be in good health
with occasional sinusitis symptoms and a watery rhinorrhea.
She regularly took euthyrox for hypothyroidism and
symbicort for light asthma symptoms. She had a strong history
of atopy with allergies to dog hair, house dust mites, birch, and
books.
Clinical examination revealed a very discrete asymmetry of
the nasolabial fold without overlying skin changes or associ-
ated pain (Fig. 1). Naso-endoscopy was poorly tolerated with
repeated sneezing but showed no signs of polyposis, patho-
logical secretions, or signs of acute sinusitis. Oral examination
showed a good dentition without any root canal work.
The patient was asked to finish her course of antibiotics and
return in 1 week or sooner if there were any substantial changes.
At follow-up examination, she presented with three palpable
pea-sized lesions, two in the left nasolabial fold and one on the
inferior left lip. All lesions were bimanually intra/extra-orally
palpable, nonpainful, smooth, and rubbery in consistency. De-
spite being easily palpable, they were not obvious on visual
inspection or on ultrasound examination. Magnetic resonance
imaging (MRI, Fig. 2) showed two poorly demarcated lesions
with contrast uptake, and computed tomography (CT) showed
reactive inflammatory changes of the underlying bone thought
to represent an atypical infective process such as actinomycosis.
Freehand fine needle aspiration cytology showed a granu-
lomatous reaction with foreign body giant cells on a
T. Pézier (*) :G. Morand : T. Kleinjung
Department of Otorhinolaryngology, University Hospital Zurich,
Frauenklinikstrasse 24, Zurich, Switzerland
e-mail: tfrpezier@gmail.com
V. Tischler
Department of Pathology, University Hospital Zurich,
Frauenklinikstrasse 24, Zurich, Switzerland
Eur J Plast Surg (2014) 37:45–48
DOI 10.1007/s00238-013-0883-7
nonbirefringent gelatinous violet substance in direct smears
stained with papanicolaou and cytoblocks stained with hema-
toxylin and eosin (H&E) (Fig. 3). Localization of the material
together with the cytomorphology and review of the literature
was suggestive of a foreign body reaction to cosmetic filler.
When told of the results, the patient admitted to multiple
cosmetic injections in the nasolabial folds as well as the lips
bilaterally, a full year previously with Belotero®, (Merz
Pharma GmbH, Dassau-Rosslau, Germany). The supplier
was contacted and the serial number of the injection noted.
The patient was treated expectantly without any steroids or
further antibiotics, but a week later, presented with two further
pea-sized finds in the left nasolabial fold. Despite having also
had simultaneous injections on the right, there were no clinical
findings on this side. A further 2 weeks later, however, she had
multiple further lesions bilaterally.
Steroids were discussed with the patient, but in the end, she
was given ibuprofen with a proton pump inhibitor for stomach
protection. The lesions were waxed and waned over the ensu-
ing 3 months, and she is still under observation.
Discussion
Dermal fillers are a nonsurgical alternative used in facial
cosmetics to eliminate wrinkles and contour tissue, allowing
a temporary amelioration of age-related or posttraumatic/
surgical facial findings. They can also be used to increase lip
volume. Over the years, many different substances have been
used including injectable paraffin and liquid silicones. Bovine
collagen was popular for many years but can cause
Fig. 2 T1 axial MRI showing left-sided diffuse lesion in the nasolabial
fold
Fig. 3 Foreign body giant cells (arrow) and pale blue material corre-
sponding to hyaluronic acid (cell block from FNA, H&E staining)
Fig. 1 Clinical photos showing subtle swelling on the left nasolabial fold
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nonhypersensitivity necrosis or hypersensitivity reactions
with antibovine antibodies. More recently, hyaluronic acid
(HA) derivatives have gained widespread popularity. They
not only have an immediate physical affect but also induce
natural collagen production. Normally, age-related decreased
production of collagen by fibroblasts occurs[3], resulting in
loss of tissue bulk and elasticity. By providing a scaffold, HA
fillers can stimulate collagen production and thereby strength-
en and support the skin.
HA derivatives are polysaccharides naturally found
throughout the body and in the cell coat of many strains of
bacteria[4]. As a biodegradable filler, they are thought to be
safer to use than nonbiodegradable fillers.When appropriately
cross-linked with denser molecular structures, they have a
lifespan of up to a year before being degraded by the body[5,
6]. Two different processes are available to obtain HA deriv-
atives: extraction from cock’s combs or by bacterial fermen-
tation of specific strains of streptococci [7]. The synthetic HA
filler is biocompatible, biodegradable, nonantigenic, nontoxic,
and though long lasting, fully absorbable.
The perfect dermal filler should be safe, easy to use, cost-
effective, adequately restore tissue contour, and have a low
risk of complications [8]. Beyond this, patient factors such as
autoimmune disorders, immunosuppressive therapy, and cos-
metic factors, such as size and location of the defect, need to
be borne in mind before choosing the appropriate interven-
tional course. For a thorough overview of available fillers, the
reader is referred to another publication [9].
Preoperative testing is encouraged with many dermal
fillers. For example, bovine collagen has a 3 % patient sensi-
tivity, and it is therefore recommended that two separate skin
tests are preoperatively performed [10, 11]. Despite this, late
reactions have still been reported [7]. Skin testing is not
routinely performed with HA injections as it is thought to be
less immunogenic [12].
When complications occurs, they can be categorized as
immediate (allergy/hypersensitivity, anaphylaxis), early
(swelling, erythema, infection), late (granuloma), or perma-
nent (scarring) [13]. Transient redness, bruising, swelling,
pain, and tenderness have been reported in 3–5 % of patients
within 14 days of HA injections [6], but long term complica-
tions are rare [14, 15].
Granuloma development following HA injections has even
been reported up to 4 years after injection in between 0.01 and
1.0 % of the patients [7, 16–18] [19, 20]. This despite the fact
that the body in theory should have biodegraded the filler well
before.
Microscopically, the foreign body granuloma consists of
macrophages congregating in multinucleated giant cells
attempting to phagocytose the filler. The resulting mass takes
on an epithelial-like appearance and is often referred to as
epithelioid. Lymphocytes surround the epithelioid mass and
produce cytokines leading to chronic inflammation [12].
Unfortunately, it remains unclear what the risk factors and
triggers for late granuloma are. One possibility is that an
infectious agent, introduced at the time of injection, forms a
relatively inert biofilm around the filler. At a later stage, a
trigger such as surgery, trauma, or infection can lead to an
acute inflammatory response [12, 21]. Though immediate
hypersensitivity reactions to HA are rare, another possibility
is a late hypersensitivity reaction [16]. Often, reactions can
remain discrete despite extensive and bilateral initial injec-
tions. We can speculate that our patient’s strong history of
atopy might have played a role in her late reaction.
In terms of treatment options, spontaneous resolution has
been observed but may take several months [17]. However,
further progression, as in our case, can also occur. Further-
more, because often the granulomas are in particularly cos-
metically sensitive areas, even small reactions can be very
distressing for the patient. A variety of treatments are avail-
able, though with varying levels of evidence. Simple massage
therapy may help to disperse the reaction and at least gives the
patient the impression that they are taking action. Medications
such as steroids can be used to suppress the immune reaction
and both intralesional injections and systemic steroids have
been used [16]. More exotic medications such as minocycline
and imiquimod can modulate the immune response [16, 17],
and even powerful immune suppressants such as cyclosporine
[7] and tacrolimus [7, 11] have been reported. Surgery can be
used on well-defined, excisable lesions when the resulting
scar can be well disguised, for example in the nasolabial fold.
On a closing note, we would like to highlight that the
regulatory background as to who can administer what fillers
varies from country to country. Often, there is actually very
little regulation. In the UK, the Medicine and Healthcare
Products Regulatory Agency specifically has not licensed
many products for general cosmetic procedures despite their
widespread use. In the aftermath of recent PIP breast implant
scandal, which resulted in thousands of women being sched-
uled for reoperation, this regulatory environment is certain to
change. To what extent, a manufacturer is liable for the
undesired affects of a product and what disclaimers should
be included in the insert is also unclear. Furthermore, “who” is
allowed to perform cosmetic procedures, in what setting, and
what training they should have are also contentious. If cos-
metic surgeons are not to fall into disrepute, it will be impor-
tant for patients to trust their surgeon and some form of
increased regulation is likely inevitable.
Conclusions
HA dermal fillers, while representing a major step forward
from older preparations, are not risk free. Patients are often
very aware of their appearance and are quick to notice small
irregularities. The optimal treatment of late granulomas is
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controversial though many surgeons advocate the use of ste-
roids. We therefore recommend careful pretreatment counsel-
ing of patients with respect to this complication.
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